Technology Alpha Tau Announces Alpha DaRT Treatment of First Two Patients in its Pivotal Multicenter Recurrent… GlobeNewswire Mar 9, 2023 -First two US patients with recurrent cutaneous squamous cell carcinoma have been treated at University Cancer Center in Houston, Texas -Up to 86…
Healthcare Management Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head… AIT News Desk Jan 3, 2022 Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced that it has been notified by HekaBio…